Polycystic ovary syndrome and impact on health

Middle East Fertility Society Journal

Volumn 16, Issue 1, 2011, Pages 19-37

  Allahbadia, Gautam N ^a   Merchant, Rubina ^a  

^a Near Otters Club   (India)

Author keywords

Adolescence; Biochemical dysfunction; Endocrine dysfunction; Etiology; Inheritance; Metabolic dysfunction; Metabolic syndrome; Obesity; Origin; Pathophysiology; Polycystic ovary syndrome; Reproductive dysfunction; Treatment

Indexed keywords

ANTIANDROGEN; AROMATASE INHIBITOR; CLOMIFENE CITRATE; CYTOCHROME P450C17; FOLLITROPIN; GONADORELIN; INHIBIN; INSULIN; INSULIN RECEPTOR; LEPTIN; LUTEINIZING HORMONE; METFORMIN; PLACEBO; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; TESTOSTERONE;

ACANTHOSIS NIGRICANS; ACNE VULGARIS; ADOLESCENT HEALTH; ALOPECIA; ANOVULATION; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOCRINE DISEASE; ENDOMETRIUM CANCER; ENZYME ACTIVATION; EXERCISE; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GENETIC PREDISPOSITION; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INHERITANCE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LUTEINIZING HORMONE RELEASE; MENSTRUATION DISORDER; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PRECOCIOUS PUBERTY; PROTEIN PHOSPHORYLATION; REVIEW; STEROIDOGENESIS; TESTOSTERONE SYNTHESIS; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 79960448021     PISSN: 11105690     EISSN: 20903251     Source Type: Journal    
DOI: 10.1016/j.mefs.2010.10.002     Document Type: Note

References (89)

1. Witchel SF. Puberty and polycystic ovary syndrome. Mol Cell Endocrinol 2006;254-255:146-53. (Pubitemid 44041765)
2. Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl 2006;29:278-85.
3. Xita N, Georgiou I, Tsatsoulis A. The genetic basis of polycystic ovary syndrome. Eur J Endocrinol 2002;147:717-25. (Pubitemid 36032959)
4. Mastorakos G, Lambrinoudaki I, Creatsas G. Polycystic ovary syndrome in adolescents: current and future treatment options. Paediatr Drugs 2006;8:311-8. (Pubitemid 44607536)
5. Hassa H, Tanir HM, Yildiz Z. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism. Arch Gynecol Obstet 2006;274:227-32. (Pubitemid 43962169)
6. Jakubowski L. Genetic aspects of polycystic ovary syndrome. Endokrynol Pol 2005;56:285-93 [in Polish].
7. Kent SC, Legro RS. Polycystic ovary syndrome in adolescents. Adolesc Med 2002;13:73-88, vi.
8. Xita N, Tsatsoulis A. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 2006;91:1660-6.
9. Isikoglu M, Berkkanoglu M, Cemal H, Ozgur K. Polycystic ovary syndrome: what is the role of obesity? In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 157-63.
10. Balen A, Michelmore K. What is polycystic ovary syndrome? Are national views important? Hum Reprod 2002;17:2219-27. (Pubitemid 35021439)
11. Barontini M, García-Rudaz MC, Veldhuis JD. Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome. Arch Med Res 2001;32:544-52. (Pubitemid 34031746)
12. Borini A, Dal Prato L. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 221-32.
13. Abdallah MA, Johnny A. The pathophysiology of polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 93-101.
14. McCartney CR, Eagleson CA, Marshall JC. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome. Semin Reprod Med 2002;20:317-36.
15. Ropelato MG, Garcia-Rudaz MC, Castro-Fernandez C, Ulloa- Aguirre A, Escobar ME, Barontini M, et al.. A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome. J Clin Endocrinol Metab 1999;84:4629-36.
16. Emperauger B, Kuttenn F. Polycystic ovarian dystrophies. Diagnostic criteria and treatment. Presse Med 1995;24:863-8 [in French].
17. Cumming DC, Reid RL, Quigley ME, Rebar RW, Yen SS. Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome. Clin Endocrinol (Oxf) 1984;20:643-8. (Pubitemid 14105337)
18. Spritzer PM, Poy M, Wiltgen D, Mylius LS, Capp E. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements. Hum Reprod 2001;16:1340-6. (Pubitemid 32640305)
19. ESHRE/ASRM. ESHRE/ASRM Rotterdam Consensus Meeting Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
20. Marshall JC, Eagleson CA. Neuroendocrine aspects of polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28:295-324. (Pubitemid 29242715)
21. Legro RS, Driscoll D, Strauss III JF, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. PNAS 1998;95:14956-60. (Pubitemid 29003738)
22. Barnes RB. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies. J Endocrinol Invest 1998;21:567-79. (Pubitemid 28532464)
23. Nelson VL, Qin Kn KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, et al.. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:5925-33. (Pubitemid 33152646)
24. Nair S. Hirsutism and acne in polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 175-90.
25. van der Spuy ZM, Dyer SJ. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:755-71. (Pubitemid 40424609)
26. Charnvises K, Weerakiet S, Tingthanatikul Y, Wansumrith S, Chanprasertyothin S, Rojanasakul A. Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome. Gynecol Endocrinol 2005;21: 161-4. (Pubitemid 41597557)
27. Kevenaar ME, Themmen AP, van Kerkwijk AJ, Valkenburg O, Uitterlinden AG, de Jong FH, et al.. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome. Hum Reprod 2009;24:241-9.
28. Franks S, Mason H, Willis D. Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol 2000;163:49-52. (Pubitemid 30645584)
29. Goldzieher JW, Green JA. The polycystic ovary. I. Clinical and histologic features. J Clin Endocrinol Metab 1962;22:325-38.
30. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, et al.. Formation and early development of follicles in the polycystic ovary. Lancet 2003;362:1017-21. (Pubitemid 37186878)
31. MacDougall MJ, Tan SL, Jacobs HS. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992;7:597-600.
32. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002;17:2858-64. (Pubitemid 35350902)
33. Wood JR, Ho CK, Nelson-Degrave VL, McAllister JM, Strauss 3rd JF. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J Reprod Immunol 2004;63:51-60. (Pubitemid 38988254)
34. Davies MJ. Evidence for effects of weight on reproduction in women. Reprod Biomed Online 2006;12:552-61. (Pubitemid 43674926)
35. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycysticovary syndrome. J Clin Endocrinol Metab 2005;90:1929-35. (Pubitemid 40586223)
36. Zeyneloglu HB, Esinler I. Chronic complications of polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 102-12.
37. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 2003;52:908-15. (Pubitemid 36957780)
38. Allahbadia GN, Merchant R. PCOS in the Indian subcontinent. Semin Reprod Med 2008;26:22-34.
39. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms and implication for pathogenesis. Endocr Rev 1997;18:774-800. (Pubitemid 28009567)
40. Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59:141-54. (Pubitemid 38140845)
41. Vignesh JP, Mohan V. Polycystic ovary syndrome: A component of metabolic syndrome? J Postgrad Med 2007;53:128-34. (Pubitemid 46808818)
42. Dogan E, Gulekli B. The role of serum leptin elevation in obese women with polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 164-72.
43. Waterworth DM, Bennett ST, Gharani N, McCarthy MI, Hague S, Batty S, et al.. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 1997;349:986-90. (Pubitemid 27149802)
44. Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 2002;174:1-5. (Pubitemid 34830927)
45. Witchel SF, Smith R, Tomboc M, Aston CE. Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril 2001;75:724-30. (Pubitemid 32273510)
46. Bach LA. The insulin-like growth factor system: basic and clinical aspects. Aust N Z J Med 1999;29:355-61. (Pubitemid 29322905)
47. Andersen PH, Kristensen K, Pedersen SB, Hjollund E, Schmitz O, Richelsen B. Effects of long-term total fasting and insulin on ob gene expression in obese patients. Eur J Endocrinol 1997;137:229-33. (Pubitemid 27405105)
48. Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2000;52:81-6. (Pubitemid 30108288)
49. Jamal K, Ozgur K. Predictors of dyslipidemia in women with polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 193-202.
50. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-9. (Pubitemid 29036695)
51. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 1992;71:599-604. (Pubitemid 23050339)
52. Agarwal SK, Vogel K, Weitsman SR, Magoffin DA. Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab 1999;84:1072-6. (Pubitemid 29138245)
53. Machtinger R, Seidman D. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 33-7.
54. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease: detection and prevention. Circulation 2003;107:363-9. (Pubitemid 36158034)
55. Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K, et al.. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res 2005;37:438-44. (Pubitemid 41081225)
56. Norman RJ, Masters L, Milner CR, Wang XJ, Davies MJ. Relative risk of conversion from normoglycemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001;16:1995-8. (Pubitemid 32916235)
57. Wijeyaratne CN, Waduge R, Arandara D, Arasalingam A, Sivasuriam A, Dodampahala SH, et al.. Metabolic and polycystic ovary syndromes in indigenous South Asian women with previous gestational diabetes mellitus. BJOG 2006;113:1182-7. (Pubitemid 44401213)
58. Gadducci A, Gargini A, Palla E, Fanucchi A, Genazzani AR. Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecol Endocrinol 2005;20:200-8. (Pubitemid 40862906)
59. Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med 2008;26:62-71.
60. Legro RS. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2002;15(Suppl. 5):1367-78. (Pubitemid 36024209)
61. Arora S, Allahbadia GN. Early origins of polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 3-12.
62. Ibáñez L, Díaz R, Ló pez-Bermejo A, Marcos MV. Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Rev Endocr Metab Disord 2009;10:63-76.
63. Otto-Buczkowska E, Jarosz-Chobot P, Deja G. Early metabolic abnormalities-insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome. Przegl Lek 2006;63:234-8 [in Polish].
64. Glueck CJ, Morrison JA, Wang P. Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with olycystic ovary syndrome. J Pediatr Endocrinol Metab 2008;21:973-84.
65. Abbott DH, Tarantal AF, Dumesic DA. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol 2009;71:776-84.
66. Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: A developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 2005;11:357-74. (Pubitemid 40895465)
67. Schleussner E. Intrauterine programming of reproductive function - a valid concept? Gynakol Geburtshilfliche Rundsch 2009;49:2-7 [in German].
68. Dumesic DA, Abbott DH, Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 2007;8:127-41. (Pubitemid 47434646)
69. Wells JC, Chomtho S, Fewtrell MS. Programming of body composition by early growth and nutrition. Proc Nutr Soc 2007;66:423-34. (Pubitemid 47076239)
70. Oken E, Gillman MW. Fetal origins of obesity. Obes Res 2003;11:496-506. (Pubitemid 41202408)
71. Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr 2004;134:205-10. (Pubitemid 38057450)
72. Franks S, Gharani N, McCarthy M. Genetic abnormalities in polycystic ovary syndrome. Ann Endocrinol (Paris) 1999;60:131-3. (Pubitemid 29359904)
73. Strauss 3rd JF. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Ann NY Acad Sci 2003;997:42-8.
74. Urbanek MT. He genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2007;3:103-11.
75. Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 2002;78:569-76.
76. Arora S, Allahbadia GN. Familial associations in women with polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 85-90.
77. Kaushal R, Parchure N, Bano G, Kaski JC, Nussey SS. Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries. Clin Endocrinol (Oxf) 2004;60:322-8. (Pubitemid 38297122)
78. Sanders EB, Aston CE, Ferrell RE, Witchel SF. Inter- and intrafamilial variability in premature pubarche and polycystic ovary syndrome. Fertil Steril 2002;78:473-8.
79. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol 2008;199:596-609.
80. Hart R. Definitions, prevalence and symptoms of polycystic ovaries and the polycystic ovary syndrome. In: Allahbadia GN, Agrawal R, editors. Polycystic ovary syndrome. UK: Anshan Publishers; 2006. p. 15-26.
81. Arslanian SA, Lewy V, Danadian K, Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: Amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 2002;87: 1555-9. (Pubitemid 34615238)
82. Pillai A, Bang H, Green C. Metformin and glitazones: do they really help PCOS patients? J Fam Pract 2007;56:444-53. (Pubitemid 47015390)
83. Essah PA, Wickham EP, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. Clin Obstet Gynecol 2007;50:205-25. (Pubitemid 46279863)
84. Ho FL, Liew CF, Cunanan EC, Lee KO. Oral hypoglycaemic agents for diabetes in pregnancy - an appraisal of the current evidence for oral anti-diabetic drug use in pregnancy. Ann Acad Med Singapore 2007;36:672-8. (Pubitemid 47378221)
85. Stadtmauer L, Oehninger S. Management of infertility in women with polycystic ovary syndrome: A practical guide. Treat Endocrinol 2005;4:279-92. (Pubitemid 43126996)
86. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulinsensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010;20(1):CD003053.
87. Tarlatzis BC, Fauser BC, Legro RS, Norman RJ, Hoeger K, Pasquali R, et al.. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008;89:505-22.
88. Farquhar CM. The role of ovarian surgery in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:789-802. (Pubitemid 40424611)
89. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: A position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009;92:1966-82.